Adherence to Timely Vaccinations in the United States.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
03 2020
Historique:
accepted: 27 11 2019
pubmed: 23 2 2020
medline: 15 5 2020
entrez: 23 2 2020
Statut: ppublish

Résumé

To estimate (1) the proportion of children not adhering to the Advisory Committee on Immunization Practices (ACIP) recommended early childhood immunization schedule and (2) associations between schedule adherence, sociodemographic characteristics, and up-to-date immunization status by 19 to 35 months of age. We used 2014 National Immunization Survey provider-verified vaccination data to classify vaccination patterns as "recommended" (ie, in line with ACIP dose- and age-specific recommendations), "alternate" (ie, in line with either limiting the number of shots per visit or skipping at least 1 vaccine series), or "unknown or unclassifiable" (ie, not in line with ACIP recommendations or clearly limiting shots per visit or vaccine series). We evaluated the association between vaccination patterns and up-to-date status for all ACIP-recommended vaccinations (including rotavirus and hepatitis A vaccines) using Poisson regression. The majority of children's patterns were classified as "recommended" (63%), with 23% and 14% following alternate or unknown or unclassifiable patterns, respectively; 58% of children were up-to-date with all ACIP-recommended immunizations by 19 to 35 months. Not being up-to-date was associated with alternate (prevalence ratio = 4.2, 95% confidence interval: 3.9-4.5) and unknown or unclassifiable (prevalence ratio = 2.4, 95% confidence interval: 2.2-2.7) patterns. High vaccine coverage by 19 to 35 months of age may miss nonadherence to the recommended immunization schedule in the first 18 months of life, leaving children vulnerable to preventable diseases. With more than one-third of US children not following the ACIP schedule, targeted interventions are needed to minimize vaccine delays and disease susceptibility.

Identifiants

pubmed: 32086389
pii: peds.2019-0783
doi: 10.1542/peds.2019-0783
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : K01 AI106961
Pays : United States

Informations de copyright

Copyright © 2020 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Auteurs

Allison L Hargreaves (AL)

Hubert Department of Global Health and.
Division of Infectious Diseases, Department of Medicine, School of Medicine, and.

Glen Nowak (G)

Grady College of Journalism and Mass Communication, University of Georgia, Athens, Georgia.

Paula Frew (P)

Hubert Department of Global Health and.
Division of Infectious Diseases, Department of Medicine, School of Medicine, and.

Alan R Hinman (AR)

Task Force for Global Health, Decatur, Georgia.

Walter A Orenstein (WA)

Division of Infectious Diseases, Department of Medicine, School of Medicine, and.
Emory Vaccine Center, Emory University, Atlanta, Georgia.

Judith Mendel (J)

National Vaccine Program Office, Department of Health and Human Services, Washington, DC; and.

Ann Aikin (A)

National Vaccine Program Office, Department of Health and Human Services, Washington, DC; and.

Jessica A Nadeau (JA)

Institute for Health and the Environment, School of Public Health, State University of New York-University at Albany, Rensselaer, New York.

Louise-Anne McNutt (LA)

Institute for Health and the Environment, School of Public Health, State University of New York-University at Albany, Rensselaer, New York.

Allison T Chamberlain (AT)

Department of Epidemiology, Rollins School of Public Health.

Saad B Omer (SB)

Hubert Department of Global Health and.
Emory Vaccine Center, Emory University, Atlanta, Georgia.
Department of Epidemiology, Rollins School of Public Health.

Laura A Randall (LA)

Hubert Department of Global Health and.
Division of Infectious Diseases, Department of Medicine, School of Medicine, and.

Robert A Bednarczyk (RA)

Hubert Department of Global Health and rbednar@emory.edu.
Emory Vaccine Center, Emory University, Atlanta, Georgia.
Department of Epidemiology, Rollins School of Public Health.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH